This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.
Partnering with Cogstate, the company is seeking to enhance its eCOA solution, with the goal of ultimately boosting the speed and effectiveness of trials.
A leader with the health data specialists looks at how COVID-19 has impacted the clinical research industry, and what the future of the field might look like.
The companies will work together on putting in place technology to facilitate remote monitoring and document review for COVID-19 studies and other research.
A leader from the healthcare solutions firm shares perspective on how application of advanced technologies has driven the evolution of the entire industry.
The UK-based collaboration will include expertise across more than 40 types of cancer, with access to patients from more than 170 referring oncologists.
The clinical trial site network company's survey of participants offers information that could shed light on ways to improve recruitment and retention.
The two companies will work together to promote technology for at-home clinical research conducted in trials focused on developing respiratory therapies.
After receiving FDA approval, the pharmaceutical company has announced plans to launch a Phase I trial for an inhaled version of the COVID-19 treatment.
With its purchase of ADPM Wearable Technologies, the technology provider is looking to provide more cost-effective, efficient data gathering solutions.
The pharmaceutical company shares details from an ongoing trial looking into the effectiveness of a pair of drugs on treating triple-negative breast cancer.
The company's cloud-based data collection solution designed to help clinical trials better manage multiple sources for greater efficiency and accuracy.
A comprehensive dive into the contract research organization field offers a glimpse into how the virus has affected firms, and what the future might hold.
A leader from the contract research organization explains how home health personnel, decentralized trial technology and other services can help avoid study interruptions
A leader with the patient recruitment specialist talks about the need for clinical trials to balance their important work with what’s important to participants.
